Our Researchers

The Snowdome Foundation supports exceptional Australian researchers and their dedication to advancing diagnostic tools and
treatments for blood cancer patients. Over the past 14 years, Snowdome has supported 70 research projects, which has enabled
over 101 research positions focused on different types of blood cancer. We are delighted to showcase the life-changing work of
these talented researchers and we remain committed to promoting collaboration between researchers and individuals who are
passionate about contributing to blood cancer research.

Since 2010, Snowdome has supported the following researchers:

 

 

A/Prof Mary Ann Anderson A/Prof Amit Khot Prof Jake Shortt
A/Prof Paul Beavis Tracy King Prof Andrew Spencer
A/Prof Piers Blombery Dr Jamie Kuzich Prof Jeff Szer AM
Dr Charles de Bock Emily Li Dr Peter Tan
Prof Richard Boyd Prof Richard Lock Dr Siok Tey
Dr Nicole Brooks Dr Kylee MacLachlan A/Prof Daniel Thomas
Prof Chan Cheah Prof Ravi Majeti Dr Ella Thompson
Dr Katherine Cummins Dr Jacek Marzec Dr Joshua Tobin
Prof Mark Dawson Dr Elizabeth Moore Prof Judith Trotman
Prof Michael Dickinson Prof Charles Mullighan Dr Ashwin Unnikrishnan
Dr Pilar Dominguez Prof Stephen Nutt Dr Kate Vandyke
Dr Katie Fennell A/Prof Jane Oliaro Dr Meaghan Wall
Dr Gareth Gregory Dr Michael Osborn Prof Andrew Wei
Prof Sean Grimmond Prof John Pimanda A/Prof David Westerman
Dr Carolyn Grove Prof Miles Prince AM Dr Carrie van der Weyden
Dr Belinda Guo Dr Indu Raman Dr Simon Willis
A/Prof Eliza Hawkes Dr Matthew Rees Dr Colin Wood
James Hicks Prof David Ritchie Dr Costas Yannakou
Prof Ricky Johnstone Prof Andrew Roberts AM Dr Paul Yeh
A/Prof Lev Kats A/Prof David Ross Dr Jessie Zhao
A/Prof Melita Kenealy Muhammed B. Sabdia

International Reach

International collaboration and the exchange of knowledge play a crucial role in the advancement of translational research into innovative treatment options. Snowdome has collaborated with the Leukemia & Lymphoma Society (LLS) in the United States and the Leukaemia Foundation in Australia to drive forward ground-breaking blood cancer research via the LLS Translational Research Program. The program focuses on accelerating research that shows significant potential of translating into new clinical applications.

 

 

Now into its fifth year, the collaboration between our organisations has resulted in the funding of ten Australian research projects, worth a total of AUD $9 million.
Get in touch

Get in contact

Get in touch
I agree to the privacy policy.